Tuesday, April 13, 2021 5:03:09 PM
(1) Seems possibly quite cheap. 12/14/20: H.C. Wainwright analyst Patrick Trucchio took over coverage of Homology Medicines and kept a Buy rating on the shares with a $30 price target. The analyst views Homology as a differentiated gene therapy and editing platform company
(2) They use spike proteins to insert their gene editing technolgy? And the coranavirus vaccines tell our immune systems to disable spike proteins? Does their technology still work in a post vaccine world? (And I understand little about these things and a little knowledge can be very dangerous)
If I knew which of these thoughts was right I would know whether to buy or not. Probably will buy a little tommorrow if it holds today low (6.80 ish) anyway. Edit: the heck with it I'll buy a little right now (afterhours) for 7.19. Would like to see it do a morningstar doji.
Recent FIXX News
- Homology Medicines Declares Distribution to Common Stockholders • GlobeNewswire Inc. • 03/18/2024 08:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/11/2024 11:37:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:32:56 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/21/2024 09:04:56 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/15/2024 05:15:36 AM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 02/13/2024 03:11:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:54:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:49:06 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/03/2024 09:29:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 09:26:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:15:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:15:15 PM
- Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency • GlobeNewswire Inc. • 01/03/2024 09:08:55 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:05:19 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 09:19:25 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 09:16:27 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 09:13:55 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 12:46:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 12:45:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 12:17:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 12:16:09 PM
- Q32 Bio and Homology Medicines Announce Merger Agreement • GlobeNewswire Inc. • 11/16/2023 12:05:00 PM
- Q32 Bio and Homology Medicines Announce Merger Agreement • PR Newswire (US) • 11/16/2023 12:05:00 PM
- Homology Medicines Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/14/2023 09:33:57 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM